Otonomy Inc (NASDAQ: OTIC) recently updated its shareholders and third parties about the status of its latest product OTO -413 clinical trials. The company revealed that the clinical trials revealed productive results from the study’s second phase. The clinical trial also revealed that one injection containing a small amount of OTO- 413 combined with an encouraged exposure of the brain neurotrophic factor created a sound and offered a relevant form of treatment to individuals with hearing difficulties.
Deaf patients struggle when in noisy environments
Barbara Shinn- Cunningham, one of the company’s spokesperson, stated that one of the difficulties experienced by patients suffering from hearing difficulties is struggling to understand their counterparts if they are in a noisy environment. Cunningham further stated that she was excited about the progress of OTO-413 and was anticipating the significance of treating patients with hearing difficulties.
Several scientific studies revealed that the reason an individual acquires hearing difficulties is a result of the reduction of inner hair cells and auditory nerve fibres. Previous studies calculated the number of people suffering from hearing problems to be 50 million Americans. This problem causes various complications, including depression and hearing loss.
OTTO-413 has shown positive results during studies
To cope with the illness, scientists developed the hearing aid. However, it possesses several restricted advantages; thus, the Food and Drug Administration has not consented to include any other treatments. The company, however, revealed that OTO-413 was created as a drug that repairs damaged areas and leads to better hearing processes. So far, OTTO-413 has been successful during the hearing tests conducted during the trials.
Otonomy Inc is among the leading companies in the biopharmaceutical industry and is famous for its advancements in creating different neurological treatments. The company prides itself on creating therapies that retain potency over a single dose. As a result, their treatments are more effective and easier for patients to comply with.
Otonomy Inc also takes out patents on all its products to ensure that it significantly participates in the industry’s advancements. The products created by the company focus on treating various illnesses with no treatments.
